Express Scripts Holding Co (ESRX) Shares Bought by Riverhead Capital Management LLC

Riverhead Capital Management LLC increased its stake in shares of Express Scripts Holding Co (NASDAQ:ESRX) by 12.0% in the 3rd quarter, Holdings Channel reports. The firm owned 32,719 shares of the company’s stock after purchasing an additional 3,511 shares during the period. Riverhead Capital Management LLC’s holdings in Express Scripts were worth $3,109,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in ESRX. Acadian Asset Management LLC purchased a new stake in Express Scripts during the 2nd quarter valued at about $314,000. Migdal Insurance & Financial Holdings Ltd. grew its stake in Express Scripts by 3,048.1% during the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 1,637 shares of the company’s stock valued at $126,000 after acquiring an additional 1,585 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. grew its stake in Express Scripts by 44.7% during the 2nd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 32,125 shares of the company’s stock valued at $2,480,000 after acquiring an additional 9,925 shares in the last quarter. Alps Advisors Inc. grew its stake in Express Scripts by 10.5% during the 2nd quarter. Alps Advisors Inc. now owns 13,019 shares of the company’s stock valued at $1,005,000 after acquiring an additional 1,238 shares in the last quarter. Finally, Virginia Retirement Systems ET AL grew its stake in Express Scripts by 1,822.9% during the 2nd quarter. Virginia Retirement Systems ET AL now owns 67,300 shares of the company’s stock valued at $5,196,000 after acquiring an additional 63,800 shares in the last quarter. Hedge funds and other institutional investors own 85.02% of the company’s stock.

Express Scripts stock opened at $95.85 on Friday. Express Scripts Holding Co has a 1-year low of $66.93 and a 1-year high of $101.73. The company has a debt-to-equity ratio of 0.63, a current ratio of 0.77 and a quick ratio of 0.65. The company has a market capitalization of $55.25 billion, a PE ratio of 13.50, a PEG ratio of 1.23 and a beta of 0.88.

Express Scripts (NASDAQ:ESRX) last posted its quarterly earnings results on Wednesday, October 31st. The company reported $2.43 earnings per share for the quarter, beating the consensus estimate of $2.42 by $0.01. Express Scripts had a net margin of 4.83% and a return on equity of 25.43%. The business had revenue of $25.56 billion during the quarter, compared to analysts’ expectations of $25.11 billion. During the same quarter in the prior year, the company posted $2.51 EPS. The business’s revenue for the quarter was up 3.6% on a year-over-year basis. As a group, equities analysts forecast that Express Scripts Holding Co will post 9.08 earnings per share for the current fiscal year.

Several analysts recently issued reports on ESRX shares. BidaskClub raised shares of Express Scripts from a “hold” rating to a “buy” rating in a research note on Tuesday, September 18th. ValuEngine raised shares of Express Scripts from a “hold” rating to a “buy” rating in a research note on Monday, September 17th. Credit Suisse Group cut shares of Express Scripts from an “outperform” rating to a “neutral” rating and upped their price objective for the company from $90.00 to $96.50 in a research note on Tuesday, September 18th. Mizuho set a $101.00 price objective on shares of Express Scripts and gave the company a “hold” rating in a research note on Monday, November 5th. Finally, Royal Bank of Canada upped their price objective on shares of Express Scripts to $94.00 and gave the company an “outperform” rating in a research note on Monday, August 27th. One equities research analyst has rated the stock with a sell rating, fourteen have given a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. Express Scripts has an average rating of “Hold” and a consensus target price of $92.14.

In other news, Director Mahon Thomas P. Mac sold 5,234 shares of the stock in a transaction that occurred on Wednesday, November 7th. The shares were sold at an average price of $99.50, for a total value of $520,783.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.79% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Express Scripts Holding Co (ESRX) Shares Bought by Riverhead Capital Management LLC” was first published by Community Financial News and is the property of of Community Financial News. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US and international copyright and trademark laws. The original version of this piece of content can be read at https://www.com-unik.info/2018/12/08/express-scripts-holding-co-esrx-shares-bought-by-riverhead-capital-management-llc.html.

Express Scripts Profile

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

Featured Story: Reverse Stock Split

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit